Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 1/20 | 0.56 |
| ▸ | TGM2 | P21980 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.43 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.43 |
| ▸ | GSTO1 | P78417 | 1/20 | 0.42 |
| ▸ | GPR139 | Q6DWJ6 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | PHGDH | O43175 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27622736 | 0.86 | ACACB (0.56) | ACACBCYP2C19TSHRTDP1ALDH1A1 | |
| SCHEMBL30230775 | 0.86 | ACACB (0.56) | ACACBCYP2C19TSHRTDP1ALDH1A1 | |
| SCHEMBL8445691 | 0.84 | ACACB (0.55) | ACACBCYP2C19TSHRTDP1L3MBTL1 | |
| SCHEMBL5527681 | 0.84 | TDP1 (0.63) | ACACBTSHRTDP1ALDH1A1HPGD | |
| SCHEMBL28207649 | 0.84 | TDP1 (0.63) | ACACBTSHRTDP1ALDH1A1HPGD | |
| SCHEMBL15338427 | 0.84 | TDP1 (0.46) | ACACBTDP1L3MBTL1TAS1R3TAS1R1 | |
| SCHEMBL4415392 | 0.84 | TDP1 (0.63) | ACACBTSHRTDP1ALDH1A1HPGD | |
| SCHEMBL6832416 | 0.82 | TDP1 (0.45) | ACACBTDP1L3MBTL1TAS1R3TAS1R1 | |
| SCHEMBL30230833 | 0.81 | ACACB (0.63) | ACACBTGM2TAS1R3TAS1R1GSTO1 | |
| SCHEMBL20791688 | 0.79 | L3MBTL1 (0.53) | TDP1L3MBTL1TAS1R3TAS1R1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7312251-B2 | Synthesis of stable solutions of rare earth tris (organophosphate) in hydrocarbon solvents | RHODIA RARE EARTHS, INC. (US) | 2007-12-25 | — | — | US | disclosed |
| EP-1071687-B1 | STABLE CONCENTRATED RARE EARTH CARBOXYLATE LIQUIDS | RHODIA RARE EARTHS INC (US) | 2006-09-27 | — | — | EP | disclosed |
| CN-1231485-C | Stable concentrated rare earth carboxylate liquids | RHODIA ELECTRONIC ENGINEERING (US) | 2005-12-14 | — | — | CN | disclosed |
| US-20040192950-A1 | Synthesis of stable solutions of rare earth tris (organophosphate) in hydrocarbon solvents | YUNLU KENAN (US) | 2004-09-30 | — | — | US | disclosed |
| EP-1173448-B1 | STABLE SOLUTIONS OF RARE EARTH TRIS (ORGANOPHOSPHORUS-DERIVATIVES) | RHODIA ELECT & CATALYSIS (US) | 2004-02-25 | — | — | EP | disclosed |
| EP-1071687-A4 | STABLE CONCENTRATED RARE EARTH CARBOXYLATE LIQUIDS | RHODIA RARE EARTHS INC (US) | 2003-01-08 | — | — | EP | disclosed |
| EP-1173448-A1 | STABLE SOLUTIONS OF RARE EARTH TRIS (ORGANOPHOSPHORUS-DERIVATIVES) | Rhodia Electronics and Catalysis Inc. (US) | 2002-01-23 | — | — | EP | disclosed |
| CN-1303385-A | Stable concentrated rare earth carboxylate liquids | RHODIA ELECTRONIC ENGINEERING (US) | 2001-07-11 | — | — | CN | disclosed |
| EP-1071687-A1 | STABLE CONCENTRATED RARE EARTH CARBOXYLATE LIQUIDS | RHODIA INC. (US) | 2001-01-31 | — | — | EP | disclosed |
| WO-2000064910-A1 | STABLE SOLUTIONS OF RARE EARTH TRIS (ORGANOPHOSPHORUS-DERIVATIVES) | RHODIA ELECTRONICS AND CATALYSIS INC. (US) | 2000-11-02 | — | — | WO | disclosed |
| US-6111082-A | Stable concentrated rare earth carboxylate liquids | RHODIA RARE EARTHS INC. (US) | 2000-08-29 | — | — | US | disclosed |
| WO-1999054335-A1 | STABLE CONCENTRATED RARE EARTH CARBOXYLATE LIQUIDS | RHODIA RARE EARTHS INC. (US) | 1999-10-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040192950-A1 | Synthesis of stable solutions of rare earth tris (organophosphate) in hydrocarbon solvents | PPIP5K2, TTPA, RTF1 | ACACB 4095/4885TGM2 1400/4885CYP2C19 3381/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.